15 mg QD PF-06649751

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

15 mg QD PF-06649751
Treatment and conditionWhere it standsTrials
15 mg QD PF-06649751 for parkinson diseaseTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1